Volume 23, Number 10—October 2017
Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
|Serial no.||Age, mo/ sex||PID type||Months last OPV†||IVIG therapy||BMT||Results by collection day|
|1||48/M||SCID||37||Yes||ND||D1, VDPV3; D91, VDPV3; D175, VDPV3; D207, VDPV3; D263, VDPV3; D334, VDPV3; D369, VDPV3; D454, VDPV3; D488, VDPV3; D524, VDPV3; D550, VDPV3; D634, VDPV3; D700, VDPV3; D774, neg; D799, Neg; D840, neg; D930, neg|
|2||48/M||FLH||NA||No||ND||D1, neg; D49, P1SL; D128, neg; D241, neg|
|3||4/M||SCID||4||Yes||ND||D1, P1SL; D29, P1SL|
*BMT, bone marrow transplant; D, day of collection following first collection; FLH, familial lymphohistiocytosis; IVIG, intravenous immunoglobulin; NA, not available; ND, not done; neg, negative; OPV, oral polio vaccine; P1SL, polio1 Sabin-like; P3SL, polio 3 Sabin-like; PID, primary immunodeficiency disease; SCID, severe combined immunodeficiency; VDPV3, type 3 vaccine-derived poliovirus.
†Time from last OPV to first fecal sample collection.
- Page created: September 18, 2017
- Page last updated: September 18, 2017
- Page last reviewed: September 18, 2017
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)